Mettler-Toledo International Inc. (MTD) Stock: Price, Forecast & Analyst Target
Mettler-Toledo International Inc. (MTD) — MoonshotScore 93/100 (Exceptional band), calculated Nov 18, 2026. Price $1705.66 (-1.82%), as of the Nov 19, 2026 trading session; market cap $33.9B. Expected results Feb 4, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Mettler-Toledo International Inc. · MTD · NYSE · Healthcare · Medical - Diagnostics & Research
Research dated 2026-09-12: Mettler-Toledo sells precision instruments, inspection systems, software and related services to laboratories, manufacturers, logistics operators and food retailers. The case depends on whether that broad demand base and strong cash generation can sustain premium margins while carrying a capital structure with far more debt than cash.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Mettler-Toledo International (MTD)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.
- quarterly revenue $1.03B (Q3 FY2025, quarter ended Sep 2025)
- EPS beat 0 of the last 4 reports
- expected results Feb 4, 2027
Helping: business quality, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 92 | Exceptional | |
| 92 | Exceptional | |
| 92 | Exceptional | |
| 92 | Exceptional | |
| 93 | Exceptional | |
| 93 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $1705.66 | |
| Change on the day | -1.82% | |
| 52-week range | $1023.05–$1806.58 | |
| Market capitalisation | $33.9B | — |
| Price / earnings (trailing) | 37.03 | |
| Shares traded on the day | 127.2K | |
| Beta (volatility vs the S&P 500) | 1.17 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Mettler-Toledo International (MTD): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 19, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
One of these lenses reads this company less favourably than the MoonshotScore does: Munger lens (margin of safety). Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
The Munger lens reads the current price as overvalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Mettler-Toledo International (MTD), and what does it report?
Short answer · as of
Mettler-Toledo is not primarily a clinical diagnostics developer.
Research dated 2026-09-12.
It supplies the tools used to weigh, measure, analyze, inspect, label and trace materials and products, with LabX software managing data generated by laboratory instruments.
Reported revenue is organized around laboratory, industrial and retail products and services. Laboratory is the largest contributor, industrial is substantial, and retail is much smaller; the customer base therefore extends well beyond healthcare into food production, chemicals, logistics, electronics and academic research.
What do the latest results show for Mettler-Toledo International (MTD)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $1.03B.
Research dated 2026-09-12.
In the latest reported period, revenue, gross profit, operating profit and net income all increased from the comparable period. Gross profit advanced faster than operating expenses, lifting profitability, while revenue landed just shy of the prevailing estimate and reported earnings exceeded it.
The annual series shows revenue extending its recovery, though the latest gain in net income was comparatively restrained. Management has framed the remaining-year outlook around modest growth; that guidance is an expectation rather than an explanation for the margin improvement already recorded.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $1.03B | $217M | $10.57 (diluted) |
| Q4 FY2025 | $1.13B | $286M | $13.98 (diluted) |
| Q1 FY2026 | $947M | $169M | $8.33 (diluted) |
| Q2 FY2026 | $1.03B | $233M | $11.55 (diluted) |
What are the financial strengths and risks for Mettler-Toledo International (MTD)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Cash generation is the principal financial strength. Operating cash flow remained positive throughout the displayed history, reached the strongest level in the latest period, and consistently exceeded capital spending by a wide margin; trailing profitability and quality screens also remain strong.
The balance-sheet constraint is leverage rather than operating burn. Debt greatly exceeds cash and investments, the cash balance declined across the reported window, and liquidity ratios provide only a modest near-term cushion. Any sustained weakening in laboratory or industrial purchasing would make continued cash conversion more important for meeting obligations.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
- Rich valuation — a P/E of 37.03 runs well above the Healthcare sector’s ~21.70x, leaving little room for a miss.
What should you watch next at Mettler-Toledo International (MTD)?
Short answer · as of
The next earnings report is expected on Feb 4, 2027.
Research dated 2026-09-12.
At the coming earnings release, watch whether revenue returns to clearing consensus after the latest narrow shortfall while earnings preserves its run of positive surprises. Gross-margin retention will show whether the recent operating improvement is durable rather than confined to a favorable period.
Cash conversion deserves equal attention: operating cash flow should continue to cover capital spending comfortably, while the cash-to-debt gap should stop widening. Management’s modest growth framing and the rising longer-range revenue and earnings estimates set a clear confirmation test for demand across laboratory and industrial products.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The newest quarter held here (Q3 FY2025) was filed Nov 7, 2025 — 12 months ago.
Checked against the records this page reads, on the dates shown above.
How does Mettler-Toledo International compare with its peers?
Short answer
Mettler-Toledo International's score ranks tied for 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Compared with laboratory-focused instrument makers, Mettler-Toledo combines analytical tools with industrial weighing, product inspection, logistics measurement and fresh-food retail systems. Its largest business still serves laboratories, but the industrial operation gives the company meaningful exposure to factory quality control and material handling rather than research budgets alone.
The relevant comparison is therefore precision-workflow breadth, software and service support, margin quality and cash conversion—not a drug or diagnostic pipeline. Retail adds another distinct demand channel, though its revenue contribution is far smaller than the laboratory and industrial operations.
| Company | Price | Market value | Score |
|---|---|---|---|
| $689.65 Nov 19, 2026 | $54.3B | 96 5-pillar Nov 18, 2026 | |
| Mettler-Toledo International (MTD) — this page | $1705.66 | $33.9B | 93 |
| $80.19 Nov 19, 2026 | $29.9B | 93 5-pillar Nov 18, 2026 | |
| $646.87 Nov 18, 2026 | $18.1B | 92 5-pillar Nov 18, 2026 | |
| $210.01 Nov 18, 2026 | $31.8B | 84 5-pillar Nov 18, 2026 | |
| $175.34 Nov 19, 2026 | $49.4B | 83 5-pillar Nov 18, 2026 | |
| $74.52 Nov 19, 2026 | $35.8B | 80 5-pillar Nov 18, 2026 | |
| $258.99 Nov 19, 2026 | $28.5B | 74 5-pillar Nov 18, 2026 | |
| $190.36 Nov 19, 2026 | $14.3B | 73 5-pillar Nov 18, 2026 | |
| $257.84 Nov 18, 2026 | $42.5B | 71 5-pillar Nov 18, 2026 | |
| $370.78 Nov 18, 2026 | $30.1B | 71 5-pillar Nov 18, 2026 | |
| $151.59 Nov 19, 2026 | $16.9B | 71 5-pillar Nov 18, 2026 | |
| $327.93 Nov 19, 2026 | $15.7B | 70 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $1350.00 – $1930.00
- Consensus target
- $1611.67
- Median target
- $1587.50
Consensus record · Captured .
Measured against a quoted price of $1705.66 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Nov 12, 2026
- Transactions
- 59
- Identified insiders
- 16
- Purchases
- 0
- Sales
- 7
- Other transactions
- 52
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MTD in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MTD in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Mettler-Toledo International (MTD)?
Mettler-Toledo International Healthcare Stock: Key Questions Answered
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does LabX do within Mettler-Toledo’s laboratory offering?
LabX manages and analyzes data produced by Mettler-Toledo laboratory instruments, linking the company’s precision hardware to customers’ digital laboratory workflows.
Why do Mettler-Toledo product inspection systems matter outside laboratories?
Metal detection, X-ray inspection, checkweighing, imaging and track-and-trace systems connect Mettler-Toledo to production quality control. Demand for these products follows manufacturing and food-processing activity rather than laboratory spending alone.
Which Mettler-Toledo product group contributes the most revenue?
Laboratory products and services are the largest contributor, followed by industrial products and services. Retail weighing and related systems form a considerably smaller operation.
Can Mettler-Toledo’s cash generation offset its debt load?
Recent operating cash flow has comfortably exceeded capital spending, providing meaningful debt-service capacity. Debt nevertheless stands far above cash and investments, so the durability of that cash conversion remains central.
What is the MTD stock price today?
The last price recorded for Mettler-Toledo International Inc. (MTD), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the MTD price target?
The analyst consensus price target for Mettler-Toledo International Inc. (MTD), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 25 figures on this page — 1 from SEC filings and earnings calls, 21 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com